CytomX Therapeutics (CTMX)
Develops tumor-localized, conditionally activated oncology biologics through its PROBODY platform.
$2.77
vs last close−0.17 (−5.78%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
−$0.09
Revenue estimate
$10.4M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.22$0.27$0.00−$0.09−$0.22−$0.10−$0.09Pending
Estimate−$0.23$0.12−$0.06−$0.05−$0.08−$0.14−$0.08−$0.09
Surprise+195.7%+116.3%+98.1%−82.5%−175.0%+28.6%−16.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$38.1M$50.9M$18.7M$6.0M$661.0K$10.3M$1.4MPending
Estimate$13.0M$35.4M$18.3M$7.3M$7.3M$4.7M$12.4M$10.4M
Surprise+192.1%+43.7%+2.1%−18.6%−91.0%+119.1%−88.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.15 | — | — |
| Sep 2027 | −$0.14 | — | — |
| Jun 2027 | −$0.12 | — | — |
| Mar 2027 | −$0.11 | — | — |
| Dec 2026 | −$0.10 | — | — |
| Nov 2026 | −$0.09 | — | — |
| Aug 2026 | −$0.08 | −$0.09 | −16.8% |
| May 2026 | −$0.14 | −$0.10 | +28.6% |
| Mar 2026 | −$0.08 | −$0.22 | −175.0% |
| Nov 2025 | −$0.05 | −$0.09 | −82.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Jun 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.15 | — | — | $2.7M | — | — | — |
| Sep 2027 | −$0.14 | — | — | $2.7M | — | — | — |
| Jun 2027 | −$0.12 | — | — | $5.3M | — | — | — |
| Mar 2027 | −$0.11 | — | — | $5.3M | — | — | — |
| Dec 2026 | −$0.10 | — | — | $5.3M | — | — | — |
| Nov 5, 2026 | −$0.09 | — | — | $10.4M | — | — | — |
| Aug 6, 2026 | −$0.08 | −$0.09 | −16.8% | $12.4M | $1.4M | −88.6% | +2.7% |
| May 7, 2026 | −$0.14 | −$0.10 | +28.6% | $4.7M | $10.3M | +119.1% | −0.5% |
| Mar 16, 2026 | −$0.08 | −$0.22 | −175.0% | $7.3M | $661.0K | −91.0% | +44.2% |
| Nov 6, 2025 | −$0.05 | −$0.09 | −82.5% | $7.3M | $6.0M | −18.6% | −13.6% |
| Aug 7, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 6, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 11, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 27, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 9, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 9, 2018 | |||||||
| Mar 7, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 7, 2017 | |||||||
| May 5, 2017 | |||||||
| Mar 2, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 3, 2016 | |||||||
| May 6, 2016 | |||||||
| Mar 7, 2016 | |||||||
| Nov 23, 2015 | |||||||
| Jun 30, 2015 |